Trophoblastic Neoplasms clinical trials
The registry lists 7 studies for Trophoblastic Neoplasms across 5 countries. 2 are recruiting or about to start. 2 of them are mainly about Trophoblastic Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-13. Counting its 2 narrower conditions too, such as Gestational Trophoblastic Disease: 72 studies, 20 open.
Get an email when these change. Save the Trophoblastic Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Taiwan University Hospital (2) · Hospices Civils de Lyon (2) · Instituto do Cancer do Estado de São Paulo (1) · Eli Lilly and Company (1) · Peking Union Medical College Hospital (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Apr 2027Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors · Peking Union Medical College Hospital
- Jul 2027Agnostic Therapy in Rare Solid Tumors · Instituto do Cancer do Estado de São Paulo
Who these studies take
Of the 2 Trophoblastic Neoplasms studies recruiting now, 1 (50%) set no upper age limit and 1 (50%) stop at 75 or younger. 1 (50%) take children under 18. 2 (100%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (50%) | 0 (0%) |
| 18 | 2 (100%) | 0 (0%) |
| 30 | 2 (100%) | 0 (0%) |
| 40 | 2 (100%) | 0 (0%) |
| 50 | 2 (100%) | 0 (0%) |
| 65 | 2 (100%) | 0 (0%) |
| 75 | 1 (50%) | 0 (0%) |
| 85 | 1 (50%) | 0 (0%) |
Across all 7 studies, recruiting or not: 43% stop at 75 or younger and 29% at 65; 43% take children; 86% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. search them.
- Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic TumorsRecruitingNCT06941766Phase 1/21 country
- The French National Reference Centre of GTDRecruitingNCT028928771 country
- Agnostic Therapy in Rare Solid TumorsActive, not recruitingNCT06638931Phase 21 country
- Chemoresistance of Trophoblastic TumorsStatus unknownNCT034889011 country
- Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic DiseaseStatus unknownNCT001667901 country
- A Trial for Patients With Gestational Trophoblastic DiseaseCompletedNCT00190918Phase 21 country
- Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for ChoriocarcinomaStatus unknownNCT002941771 country